Histone deacetylases (HDACs): evolution, specificity, role in transcriptional complexes, and pharmacological actionability

G Milazzo, D Mercatelli, G Di Muzio, L Triboli… - Genes, 2020 - mdpi.com
Histone deacetylases (HDACs) are evolutionary conserved enzymes which operate by
removing acetyl groups from histones and other protein regulatory factors, with functional …

Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications

Q Zhong, X Xiao, Y Qiu, Z Xu, C Chen, B Chong… - MedComm, 2023 - Wiley Online Library
Protein posttranslational modifications (PTMs) refer to the breaking or generation of covalent
bonds on the backbones or amino acid side chains of proteins and expand the diversity of …

Role of HDACs in normal and malignant hematopoiesis

P Wang, Z Wang, J Liu - Molecular cancer, 2020 - Springer
Normal hematopoiesis requires the accurate orchestration of lineage-specific patterns of
gene expression at each stage of development, and epigenetic regulators play a vital role …

Histone modifications in epigenetic regulation of cancer: Perspectives and achieved progress

ME Neganova, SG Klochkov, YR Aleksandrova… - Seminars in Cancer …, 2022 - Elsevier
Epigenetic changes associated with histone modifications play an important role in the
emergence and maintenance of the phenotype of various cancer types. In contrast to direct …

Zinc binding groups for histone deacetylase inhibitors

L Zhang, J Zhang, Q Jiang, L Zhang… - Journal of enzyme …, 2018 - Taylor & Francis
Zinc binding groups (ZBGs) play a crucial role in targeting histone deacetylase inhibitors
(HDACIs) to the active site of histone deacetylases (HDACs), thus determining the potency …

Safety and tolerability of histone deacetylase (HDAC) inhibitors in oncology

RR Shah - Drug safety, 2019 - Springer
Histone deacetylases (HDACs) are expressed at increased levels in cells of various
malignancies, and the use of HDAC inhibitors has improved outcomes in patients with …

Strategies to design selective histone deacetylase inhibitors

J Melesina, CV Simoben, L Praetorius… - …, 2021 - Wiley Online Library
This review classifies drug‐design strategies successfully implemented in the development
of histone deacetylase (HDAC) inhibitors, which have many applications including cancer …

Targeting macrophage immunometabolism: Dawn in the darkness of sepsis

V Kumar - International Immunopharmacology, 2018 - Elsevier
Sepsis is known since the time (470 BC) of great Greek physician, Hippocrates.
Advancement in modern medicine and establishment of separate branches of medical …

c-Myc modulation and acetylation is a key HDAC inhibitor target in cancer

A Nebbioso, V Carafa, M Conte, FP Tambaro… - Clinical Cancer …, 2017 - AACR
Abstract Purpose: Histone deacetylase inhibitors (HDACi) are promising anticancer drugs.
Although some HDACi have entered the clinic, the mechanism (s) underlying their tumor …

Metabolic reprogramming by immune-responsive gene 1 up-regulation improves donor heart preservation and function

I Lei, W Huang, PE Noly, S Naik, M Ghali… - Science translational …, 2023 - science.org
Preservation quality of donor hearts is a key determinant of transplant success. Preservation
duration beyond 4 hours is associated with primary graft dysfunction (PGD). Given transport …